Details of the Drug Combinations

General Information of This Drug (ID: DMAPV1B)

Drug Name

Glatiramer Acetate DMAPV1B

Synonyms

Glatiramer acetate; Copaxone; 147245-92-9; Copolymer 1; Copolymer-1; COP-1; Protiramer; Glatopa; L-Glutamic acid peptide with L-alanine, L-lysine and L-tyrosine, acetate (salt); L-alanine compound with L-glutamic acid and L-lysine and L-tyrosine and acetic acid (1:1:1:1:1); (2S)-2,6-diaminohexanoic acid; TV 5010; UNII-5M691HL4BO; Glatirameracetat; Glatiramer acetate [USAN:BAN]; AC1MIXQC; 5M691HL4BO

Indication

Disease Entry	ICD 11	Status	REF
Multiple sclerosis	8A40	Approved	[1]
------------------------------------------------------------------------------------

Therapeutic Class

Immunosuppressive Agents

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Glatiramer acetate + Estriol	DC91HPN	Estriol	Relapsing Remitting Multiple Sclerosis	[2]
Glatiramer acetate + Salbutamol	DCFNG7Z	Salbutamol	Autoimmune Diseases	[3]
Glatiramer acetate + Teriflunomide	DCI99KB	Teriflunomide	Multiple Sclerosis	[4]
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1058).
2	ClinicalTrials.gov (NCT00451204) A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
3	ClinicalTrials.gov (NCT00039988) Treatment of Multiple Sclerosis With Copaxone and Albuterol
4	ClinicalTrials.gov (NCT00811395) Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis